Immix Biopharma Completes $5 Million At-The-Market Equity Offering Program
14 juin 2023 07h30 HE
|
Immix Biopharma, Inc.
LOS ANGELES, June 14, 2023 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc., (Nasdaq:IMMX) (“ImmixBio”, “Company”, “We” or “Us”), a biopharmaceutical company pioneering CAR-T cell therapies and tissue...